Propanc Biopharma, Inc.

Latest News

Aug 12, 2019

CORRECTING and REPLACING Propanc Biopharma Publishes Key Data in Peer Reviewed Journal Confirming Anti-Cancer Stem Cell Effects of Proenzymes

Propanc Discusses Next Steps for Promising Research Collaboration with University of Jaén and Granada to Further Optimize Quality, Safety and Performance of PRP MELBOURNE, Australia--(BUSINESS WIRE)-- First…

View All Press Releases

Aug 8, 2019

Propanc Biopharma Completes Development of Bio-analytical Assay Method to Quantify PRP’s Active Ingredients in Preparation for First-In-Human Study

Jul 15, 2019

Propanc Biopharma Provides Update on Preparation of PRP for Clinical Trial Application Submission and Recently Completed Reverse Stock Split

Jun 27, 2019

Propanc Biopharma’s Intellectual Property Portfolio Undergoes Rapid Growth
Latest Publication Pancreatic (pro)enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engrafting View All Publications
Antitumour efficacy of chymotrypsinogen and trypsinogen
In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation
A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer